#USA #San Diego #Class Action #Robbins LLP #Hims

An Urgent Call to HIMS Stockholders: Class Action Lawsuit Details

In a recent announcement, Robbins LLP, a law firm known for advocating shareholder rights, has reached out to investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding significant legal developments. A class action lawsuit has been initiated to represent all individuals and entities who purchased or obtained HIMS stocks between August 4, 2025, and July 29, 2026. This class action aims to address the alleged mishandling of customer health information and misleading marketing practices by Hims.

What Led to the Lawsuit?

The allegations stem from claims that Hims & Hers Health, which operates a digital health platform connecting users to licensed medical professionals, shared sensitive patient information with third-party advertising companies. Moreover, the company reportedly billed customers for prescriptions immediately after they filled out an intake form, failing to provide the promised consultation with a healthcare provider. This behavior has raised serious questions about the transparency and ethical standards maintained by the firm.

The FTC's Involvement

On July 29, 2026, during trading hours, the Federal Trade Commission (FTC) intervened, filing a lawsuit against Hims, claiming it deceived consumers regarding the security of their health data. This suit highlighted practices that contradicted Hims's assertions of providing a ‘100% online, private, and secure’ experience. News of the FTC's action caused Hims's stock to plummet by 14.73%, marking a critical point for investors.

Who Can Join the Class Action?

Eligible participants in this class action lawsuit include anyone who purchased Hims securities during the established class period. Given the grave nature of the allegations, investors who experienced losses during this period are encouraged to reach out to Robbins LLP for guidance. The law firm has set November 2, 2026, as a deadline for appointing a lead plaintiff, who will represent the interests of all participants throughout the litigation process. It is critical to note that participation in this lawsuit incurs no upfront costs, as Robbins LLP works on a contingency fee basis.

The Role of Robbins LLP

Robbins LLP has an extensive history of successfully guiding investors through similar situations, recovering over $2 billion for shareholders over the years. The founding partner, Brian J. Robbins, stated, “Firms must provide transparent and accurate information to investors to foster a fair market.” Investors interested in maintaining their rights should act promptly to ensure their involvement in the lawsuit.

Conclusion: Key Actions for Investors

As developments unfold in this pivotal case, HIMS & Hers Health, Inc. stockholders should remain proactive. If you purchased shares during the specified time frame and are affected by the downturn or the underlying issues within the company, contact Robbins LLP for potential legal recourse. Sign up for alerts to stay updated on the case's progress or reach out directly via their contact options for any inquiries.

Investors must act swiftly, as the window for engagement is finite. This situation serves as a reminder of the importance of corporate transparency and the rights held by shareholders.

Contact Details for Further Inquiry: For additional information about the ongoing class action against HIMS & Hers Health, Inc., reach out to Robbins LLP today by visiting their website or calling (800) 350-6003.